Emerging infectious diseases and pandemic response

FHI 360 addresses emerging pandemics and epidemics with expertise that supports health security efforts in the United States and globally, improving epidemic preparedness, detection and response. We incorporate technological innovations and use cutting-edge behavioral, sociomedical, epidemiological, laboratory and clinical research sciences to understand, prevent and contain these emerging threats.

FHI 360 has worked on outbreak preparedness and response for several pandemic threats, including COVID-19, new influenza strains like the avian flu and H1N1, Dengue fever, Ebola and Zika.

Our cross-cutting capabilities to control pandemic threats include:

Crisis response
Clinical laboratory quality assurance
Clinical trials design and research management
Food security and emergency nutrition
Health surveillance
Health systems strengthening
Infectious and tropical diseases
Laboratory strengthening
Mobile technology solutions
Product quality and compliance
Social and behavior change communication , risk communication and social marketing and communications
Water, sanitation and hygiene

Lead photo credit: Kunle Lawal/FHI 360

You are here